Open QSAR is a new site for the development and assessment of comparative QSAR modelling methodology (meta QSAR) as well being available for QSAR model building and multi-property prediction. The site uses an automated QSAR building and prediction software...

Pre-clinical drug discovery has traditionally been the preserve of large fully integrated pharmaceutical companies (FIPCOs) in established geographical centres in the UK, US and Europe. It relied on tight integration of laboratory facilities and drug design...

In a post earlier in the year I talked about the independent scientist and how very experienced people were stepping out of their careers with sufficient income to engage in science as independents, assuming that they could find ways to reproduce the networks...

Could you invent a drug for free?No. It costs on average almost $1 bn to get a new drug launched. Although much of that cost comes from counting all the failures along the way, since for every 150 drug discovery projects that get started only one, 12 years...

Open QSAR is a new site for the development and assessment of comparative QSAR modelling methodology (meta QSAR) as well being available for QSAR model building and multi-property prediction. The site uses an automated QSAR building and prediction software...

Pre-clinical drug discovery has traditionally been the preserve of large fully integrated pharmaceutical companies (FIPCOs) in established geographical centres in the UK, US and Europe. It relied on tight integration of laboratory facilities and drug design...

I had a nice long chat with David Leahy from InkSpot yesterday. There is actually a good discussion in the comments of David's most recent post.What I gathered from our conversation is that InkSpot will be providing transparency on the computational side of...